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Abstract
Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is an adverse drug reaction represented by destruction and/or death
of bone. Fibrous dysplasia (FD) is a rare bony disorder characterised by abnormal fibro-osseous tissue that has lowered
resistance to infection. Effective treatments for BRONJ that follows FD are unclear. Here, we report that advanced BRONJ
associated with FD was successfully treated by surgical resection. A 69-year-old woman, whose left maxillary bone showed
a ground glass appearance on computed tomography (CT) images, was taking alendronate. At 1 year after teeth within
the abnormal bone were extracted, exposed bone was observed in the extraction sites and CT images revealed separated
sequestrums. Under the clinical diagnosis of Stage 2 BRONJ with FD, we performed not only sequestrectomy but also a partial
resection of the FD. Thereafter, the healing was uneventful without recurrence. In conclusion, our case suggests that surgical
resection is useful for advanced BRONJ associated with FD.
INTRODUCTION
Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is
a complication caused by bisphosphonate (BP) treatment
for excessive bone resorptive diseases, such as osteoporosis
and bone metastasis [1]. The histopathological findings of
BRONJ were found to show necrotic bone and inflammation
in the same manner as those of osteomyelitis of the jaw [2],
whereas the pathophysiological mechanisms of BRONJ remain
unclear [1]. Therefore, the management of BRONJ is difficult,
which is a troublesome problem for oral and maxillofacial
surgeons. Because standard treatments for BRONJ are not yet
established, numerous studies have discussed the therapeutic
strategies. Meanwhile, recent studies have suggested that
surgical treatments are useful for Stages 2–3 BRONJ [1].
Fibrous dysplasia (FD) is a rare bony disorder affecting one
bone or multiple bones, and the affected bones are generally
conceived to be less resistant to infection [3]. Notably, FD of
the jaw bone with dental infections may be complicated by
osteomyelitis [3, 4].
There are no published reports describing surgical resection
for BRONJ associated with FD, and the usefulness of surgical
resection in such cases is unknown. Here, we demonstrate, for
the first time, that Stage 2 BRONJ associated with FD was suc-
cessfully treated by surgical resection.
CASE REPORT
A 69-year-old woman was referred to our hospital by a dentist at
another hospital because of swelling in her left maxilla. There
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Figure 1: Sagittal section of CT image showing the maxillary bone with a ground
glass appearance in distal regions from #24 part and bone resorption around #25
and #26.
was the mobility of the left maxillary second premolar and
first molar (FDI #25 and #26) and swelling of the surrounding
gingiva. Computed tomography (CT) images revealed maxillary
bone expansion with a ground glass appearance (Fig. 1). The
patient had begun steroid therapy for polymyalgia rheumatica
4.5 years earlier. Since then she had been taking alendronate,
one of the oral BPs, for the prevention of glucocorticoid-induced
osteoporosis.
The clinical diagnosis was acute periodontitis in #25 and #26
parts with FD of the left maxillary bone. After an administration
of clarithromycin, #25 and #26 were extracted, and then small
bone fragmentswere collected from the sockets for a histopatho-
logical examination. The finding of not FD but the sequestrum
predicted the occurrence of BRONJ.
At 1 year after the extractions, a purulent discharge and
exposed bone with gingival fistulas were observed in the extrac-
tion sites (Fig. 2A). CT images revealed separated sequestrums in
the left maxilla and bone resorption in the periapical area of the
left maxillary first premolar (FDI #24) (Fig. 2B). With the permis-
sion of the patient’s attending physicians, the alendronate was
withdrawn. After exposed bone had been observed for 8 weeks,
the patient was clinically diagnosed with Stage 2 BRONJ accom-
panying FD of the left maxillary bone. Under general anes-
thesia, we first performed extraction of #24 and sequestrec-
tomy. We then performed a partial resection of the FD because
necrotic-like bone fragments were collected by curettage of the
marginal bone (Fig. 3). Finally, the surgical wound was com-
pletely closed by sutures. The histopathological diagnosis was
chronic osteomyelitis with FD (Fig. 4). At 2.5 years after the
operation, the healing is uneventful although residual FD bone
exists (Fig. 5). Although local conditions permit the resumption
of alendronate, it remains discontinued at the attending physi-
cians’ discretion.
DISCUSSION
In the current position paper, surgical treatments tend to be
recommended for advanced BRONJ [1]. Surgical resection can
produce higher cure rates than local debridement [5]. In our
case, after local debridement including sequestrectomy, the
residue of necrotic bone within marginal bone of the separated
sequestrums was suspected; therefore, we added a partial
resection of the FD. Indeed, the histopathological findings of
marginal bone of the separated sequestrums shown in Fig. 4A
proved the residues of necrotic bone and inflammation; in
contrast, the histopathological findings of the resection margin
shown in Fig. 4B found no necrotic bone and inflammation. As a
result of adding the resection, the healing has been uneventful
without recurrence although residual FD bone exists. Metwally
et al. [6] reported the first cases of BRONJ associated with FD, in
which only a Stage 2 case presented continual infection despite
the combination of local debridement and antibiotic therapy.
These findings suggest that surgical resection may be more
useful than local debridement for advanced BRONJ associated
with FD.
Our patient who had been taking an oral BP for years
developed BRONJ after tooth extractions within FD bone. FD
patients have been reported to develop BRONJ after tooth extrac-
tions within FD bone despite the long-term discontinuation of
Figure 2: (A) Intraoral photograph showing gingival fistulas in #25 and #26 extraction sites (arrows). (B) Sagittal section of CT image showing separated sequestrums in
the left maxilla (arrow) and bone resorption in the periapical area of #24 (arrowhead).
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Figure 3: (A) Intraoral photograph showing a resected area. (B) Surgical speci-
mens: separated sequestrums and resected FD bone (scale bar: 5 mm).
Figure 4: Photomicropraphs showing distinct histopathological findings in sur-
gical specimens (hematoxylin-eosin stain, scale bar: 200 µm). (A) A marginal
bone fragment of separated sequestrums showing necrotic bone with typical
empty lacunae, surrounded by numerous inflammatory cells, and (B) resection
margin showing irregularly shaped trabeculae of woven bone and proliferation
of collagen fibers with fibroblasts but no necrotic bone and inflammatory cells.
intravenous BPs [6]. These findings indicate that tooth extraction
within FD bone may be a higher risk factor for BRONJ regardless
of the presence/absence of the discontinuation of BPs.
The number of patients with FD complicated by BRONJ could
increase, since FD patients can receive BP therapy for FD-related
bone pain [6–8]. Our case supports aggressive treatment such
as surgical resection for advanced BRONJ associated with FD.
Figure 5: (A) Six-month postoperative intraoral photograph showing complete
healing of a surgical wound. (B) Sagittal section of CT image showing residual
but not recurrently infected FD bone in the left maxilla after surgical resection.
However, it remains unclear whether such a surgical treatment
strategy is effective without the discontinuation of BP treatment.
Further studies are needed in order to establish therapeutic
strategies for BRONJ associated with FD.
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